Japan Lifeline Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and Year Ending March 31, 2024
August 02, 2023 at 02:10 am EDT
Share
Japan Lifeline Co., Ltd. provided consolidated earnings guidance for the Six months ending September 30, 2023 and Year ending March 31, 2024. For the period, the company expects net sales of JPY 23,880 million, operating profit of JPY 4,488 million, profit attributable to owners of parent of JPY 3,235 million and basic earnings per share of JPY 41.17.
For the year, the company expects net sales of JPY 48,807 million, operating profit of JPY 9,763 million, profit attributable to owners of parent of JPY 6,854 million and basic earnings per share of JPY 89.13.
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.
JAPAN LIFELINE CO., LTD. 
